Dasatinib

Leukemia, Myeloid, Accelerated Phase, Acute Lymphoblastic Leukemia, Chemotherapy + 4 more
Treatment
7 FDA approvals
20 Active Studies for Dasatinib

What is Dasatinib

DasatinibThe Generic name of this drug
Treatment SummaryDasatinib is a pill taken to treat chronic myelogenous leukemia (CML). The drug targets and blocks certain proteins found in cancer cells, such as BCRABL, SRC, Ephrins, and GFR.
Sprycelis the brand name
image of different drug pills on a surface
Dasatinib Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Sprycel
Dasatinib
2006
7

Approved as Treatment by the FDA

Dasatinib, also called Sprycel, is approved by the FDA for 7 uses like Myeloid Leukemia, Chronic, Chronic Phase and Chemotherapy .
Myeloid Leukemia, Chronic, Chronic Phase
Chemotherapy
blast phase Chronic myelocytic leukemia
Newly Diagnosed
Acute Lymphoblastic Leukemia
Therapeutic procedure
Leukemia, Myeloid, Accelerated Phase

Effectiveness

How Dasatinib Affects PatientsDasatinib is a drug taken by mouth that helps to stop the growth of certain cancer cells by blocking a certain type of protein found in these cells.
How Dasatinib works in the bodyDasatinib is a drug used to treat cancer. It works by blocking the activity of certain protein kinases, which are enzymes involved in cell growth and survival. Dasatinib is able to block several different types of protein kinases, including those involved in Leukemia, Chronic Myeloid Leukemia, and Acute Lymphoblastic Leukemia. It is also able to overcome resistance to other drugs caused by mutations or other factors.

When to interrupt dosage

The suggested amount of Dasatinib is contingent upon the diagnosed condition. The dosage fluctuates depending on the technique of delivery (e.g. Powder, for suspension or Oral) elucidated in the table below.
Condition
Dosage
Administration
Leukemia, Myeloid, Accelerated Phase
70.0 mg, , 20.0 mg, 50.0 mg, 100.0 mg, 80.0 mg, 140.0 mg, 10.0 mg/mL
, Oral, Tablet, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for suspension, Powder, for suspension - Oral
Newly Diagnosed
70.0 mg, , 20.0 mg, 50.0 mg, 100.0 mg, 80.0 mg, 140.0 mg, 10.0 mg/mL
, Oral, Tablet, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for suspension, Powder, for suspension - Oral
Chemotherapy
70.0 mg, , 20.0 mg, 50.0 mg, 100.0 mg, 80.0 mg, 140.0 mg, 10.0 mg/mL
, Oral, Tablet, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for suspension, Powder, for suspension - Oral
Myeloid Leukemia, Chronic, Chronic Phase
70.0 mg, , 20.0 mg, 50.0 mg, 100.0 mg, 80.0 mg, 140.0 mg, 10.0 mg/mL
, Oral, Tablet, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for suspension, Powder, for suspension - Oral
blast phase Chronic myelocytic leukemia
70.0 mg, , 20.0 mg, 50.0 mg, 100.0 mg, 80.0 mg, 140.0 mg, 10.0 mg/mL
, Oral, Tablet, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for suspension, Powder, for suspension - Oral
Acute Lymphoblastic Leukemia
70.0 mg, , 20.0 mg, 50.0 mg, 100.0 mg, 80.0 mg, 140.0 mg, 10.0 mg/mL
, Oral, Tablet, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for suspension, Powder, for suspension - Oral
Therapeutic procedure
70.0 mg, , 20.0 mg, 50.0 mg, 100.0 mg, 80.0 mg, 140.0 mg, 10.0 mg/mL
, Oral, Tablet, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for suspension, Powder, for suspension - Oral

Warnings

There are 20 known major drug interactions with Dasatinib.
Common Dasatinib Drug Interactions
Drug Name
Risk Level
Description
2-Methoxyethanol
Major
The risk or severity of adverse effects can be increased when Dasatinib is combined with 2-Methoxyethanol.
9-(N-methyl-L-isoleucine)-cyclosporin A
Major
The risk or severity of adverse effects can be increased when Dasatinib is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.
Abemaciclib
Major
The metabolism of Abemaciclib can be decreased when combined with Dasatinib.
Abetimus
Major
The risk or severity of adverse effects can be increased when Dasatinib is combined with Abetimus.
Acalabrutinib
Major
The metabolism of Acalabrutinib can be decreased when combined with Dasatinib.
Dasatinib Toxicity & Overdose RiskAnimals that overdose on this drug may experience damage to their heart.
image of a doctor in a lab doing drug, clinical research

Dasatinib Novel Uses: Which Conditions Have a Clinical Trial Featuring Dasatinib?

Presently, 177 active trials are assessing the potential of Dasatinib to provide relief for Acute Lymphoblastic Leukemia.
Condition
Clinical Trials
Trial Phases
Acute Lymphoblastic Leukemia
146 Actively Recruiting
Phase 2, Phase 3, Phase 1, Not Applicable, Early Phase 1, Phase 4
Leukemia, Myeloid, Accelerated Phase
1 Actively Recruiting
Phase 1, Phase 2
Chemotherapy
2 Actively Recruiting
Not Applicable
Myeloid Leukemia, Chronic, Chronic Phase
4 Actively Recruiting
Phase 2, Phase 1
Newly Diagnosed
3 Actively Recruiting
Phase 3, Phase 1
Therapeutic procedure
0 Actively Recruiting
blast phase Chronic myelocytic leukemia
0 Actively Recruiting

Dasatinib Reviews: What are patients saying about Dasatinib?

5Patient Review
3/24/2016
Dasatinib for Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Sprycel/Dasatinib can cause some tough side effects, like edema in the legs and feet. For me, this drug wasn't essential since I've already had a stem cell transplant. But if you're looking for a treatment that will keep your cancer in remission by itself, this might be the one for you.
5Patient Review
12/7/2020
Dasatinib for Philadelphia Chromosome Positive Chronic Myelocytic Leukemia
I've been taking dasatinib from BonHoa Pharmacy for a while now and have generally been pleased. However, I've started experiencing some new symptoms that I believe are related to the medicine. These include bone pain, difficulty breathing, and fatigue. Even so, I wouldn't want to switch medications because this is the only one I haven't had any side effects with.
5Patient Review
10/18/2007
Dasatinib for Type of Leukemia - Chronic Myelogenous Leukemia
4Patient Review
6/27/2014
Dasatinib for Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
I've been in remission for 18 months.
3Patient Review
3/30/2011
Dasatinib for Chronic Phase Chronic Myeloid Leukemia
I haven't tried it yet, but I'm interested to see how it works.
1Patient Review
5/11/2010
Dasatinib for Type of Leukemia - Chronic Myelogenous Leukemia
I was given this drug after five years of taking Gleevec, which wasn't working as well as it did in the beginning. This new drug has far fewer side effects, and my blood tests have been gradually improving since I started taking it.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about dasatinib

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is dasatinib an immunotherapy?

"The study found that drug dasatinib, which is used to treat leukemia, makes immunotherapy more effective against cancer."

Answered by AI

What is dasatinib used for?

"This medication is used to treat Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in adults and children. It is also used to treat Ph+ CML and Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL) in adults when other medicines (eg, imatinib) or treatments have not worked well."

Answered by AI

Is dasatinib a chemotherapy drug?

"A targeted therapy is a type of cancer treatment that targets the changes in cancer cells that help them grow, divide, and spread.

The trade name for the generic chemotherapy drug Dasatinib is SPRYCEL. In some cases, health care professionals may use the trade name SPRYCEL when referring to the generic drug name Dasatinib. SPRYCEL is a targeted therapy. A targeted therapy is a type of cancer treatment that targets the changes in cancer cells that help them grow, divide, and spread."

Answered by AI

What is the target of dasatinib?

"Dasatinib is an oral medication that inhibits two enzymes, BCR/ABL and Src. These are tyrosine kinases that are responsible for chronic myelogenous leukemia (CML). Dasatinib also inhibits Ephrins and GFR."

Answered by AI

Clinical Trials for Dasatinib

Have you considered Dasatinib clinical trials? We made a collection of clinical trials featuring Dasatinib, we think they might fit your search criteria.
Have you considered Dasatinib clinical trials? We made a collection of clinical trials featuring Dasatinib, we think they might fit your search criteria.
Have you considered Dasatinib clinical trials? We made a collection of clinical trials featuring Dasatinib, we think they might fit your search criteria.